SITARED M XR (Sitagliptin (100mg) + Metformin (500mg))

Product Description

Sitared-M XR 100/500 Tablet is a pharmaceutical formulation that combines two active agents aimed at managing elevated blood glucose levels in individuals diagnosed with type 2 diabetes mellitus. This medication plays a crucial role in mitigating severe diabetes-related complications, including renal impairment and visual loss, while potentially lowering the risk of cardiovascular events such as heart attacks and strokes. The administration of Sitared-M XR 100/500 Tablet may occur as monotherapy or in conjunction with other antidiabetic medications. Optimal results are achieved when this drug is paired with a balanced diet and consistent physical activity. The prescribed dosage will be tailored based on the patient’s medical condition, existing blood sugar readings, and any concurrent medications. Taking the tablet during meals can help minimize gastrointestinal discomfort. To maximize therapeutic outcomes, adherence to a regular dosing schedule is essential, and discontinuing the medication should only be done upon physician advice. Compliance with recommended dietary and exercise practices is vital for effective diabetes management. Notably, it is essential to recognize the potential side effects associated with Sitared-M XR 100/500 Tablet, including gastrointestinal upset and respiratory infections. Additionally, the risk of hypoglycemia may increase if combined with other antidiabetic agents. Prior to starting this medication, informing the healthcare provider of any previous kidney, liver, or cardiac issues, or significant alcohol consumption is crucial. Pregnant and breastfeeding women should seek medical advice before initiation. Regular assessments of kidney function and blood glucose levels will be performed during treatment to ensure safety.